Diagnostics
Four flagship multiplex PCR kits — manufactured in the Kingdom.
A focused Phase 1 portfolio targeting the Kingdom's most pressing clinical and public-health priorities: women's health, sexual health, public health, and oncology.
HPV Detection Kit
14 high-risk genotypes
Multiplex real-time PCR for HPV detection across 14 high-risk genotypes — supporting cervical-cancer screening pathways.
View kit detailsSexual HealthSTI 12-Panel
Twelve sexually transmitted infections
A single multiplex assay covering twelve clinically relevant STI targets — designed for high-throughput laboratory workflows.
View kit detailsPublic HealthDengue Detection
DENV-1, 2, 3 and 4 serotypes
Real-time PCR for differential detection of all four dengue serotypes — strengthening Hajj-season surveillance and outbreak response.
View kit detailsOncologyColorectal & Pancreatic ctDNA
Liquid biopsy for oncology
Circulating tumour DNA assay supporting non-invasive monitoring in colorectal and pancreatic oncology pathways.
View kit detailsBeyond Phase 1
A pipeline aligned with national priorities
Gene Matrix is actively developing additional molecular assays and platform capabilities. Our future pipeline includes next-generation sequencing and advanced diagnostic devices — currently in development, not yet available for clinical use.
See the future pipeline